세계의 차세대 수술용 접착제 시장 분석과 예측(-2034년) : 유형, 제품, 용도, 재료 유형, 기술, 최종 사용자, 형상, 기능성, 전개, 솔루션
Next Generation Surgical Glue Market Analysis and Forecast to 2034: Type, Product, Application, Material Type, Technology, End User, Form, Functionality, Deployment, Solutions
상품코드 : 1699130
리서치사 : Global Insight Services
발행일 : 2025년 04월
페이지 정보 : 영문 433 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,750 ₩ 6,862,000
Single User License help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능하며, 인쇄는 가능합니다.
US $ 5,750 ₩ 8,307,000
Site License help
PDF, Excel 보고서를 동일 기업(국가)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,750 ₩ 9,752,000
Enterprise License help
PDF, Excel 보고서를 동일 기업의 전 세계 모든분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세계의 차세대 수술용 접착제 시장은 2024년 28억 달러에서 2034년까지 83억 달러로 확대되어 약 11.5%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다. 기술 혁신은 생체 흡수성 재료와 강화 된 탄성에 중점을두고 심장혈관, 정형외과, 미용 수술 다양한 용도에 대응하고 있습니다. 이 시장은 수술 건수 증가와 기존의 봉합사와 스테이플을 대체하는 보다 안전하고 치유가 빠른 것에 대한 수요에 의해 견인되고 있습니다.

시장 개요:

차세대 수술용 접착제 시장은 주로 치유를 촉진하고 회복 시간을 단축하는 고도의 상처 폐쇄 솔루션에 대한 요구가 높아짐에 따라 견조한 확대를 이루고 있습니다. 시장을 리드하고 있는 것은 합성 분야로, 그 우위성은 우수한 접착 특성, 생체 적합성 및 감염 위험의 최소화로 인한 고분자 기술의 혁신은이 부문을 더욱 밀어 올리고 강도와 유연성을 향상 시켰습니다. 이 중 조직의 재생을 촉진하는 성장 인자를 통합 한 생물학적 활성 접착제의 하위 부문이 증가하고 있으며, 큰 가능성을 갖고 있습니다. 또한 침습 수술 증가는 정확한 적용과 강력한 접착을 제공하는 수술 접착제 수요를 촉진하고 시장의 성장 궤도를 더욱 견고하게 만듭니다.

시장 세분화
유형 합성, 천연
제품 액체 접착제, 페이스트, 필름
용도 내시경 수술, 외시경 수술, 상처 폐쇄, 조직 밀폐, 지혈
재료 유형 시아노아크릴레이트, 피브린 실란트, 콜라겐계, 중합체성 하이드로겔
기술 나노 기술, 생체 접착 기술
최종 사용자 병원, 외래수술센터(ASC), 클리닉
모양 액체, 젤, 스프레이
기능성 접착, 씰, 지혈, 조직 공학
배포 일회용, 재사용 가능
솔루션 상처 케어 솔루션, 수술 솔루션

차세대 수술용 접착제 시장은 생체적합성과 생분해성 접착제의 혁신을 주된 원동력으로 하는 역동적인 변화를 경험하고 있습니다. 수술이 증가함에 따라 수요는 현저하게 증가하고 있습니다. 한편, 아시아태평양에서는 건강 관리 시설의 확대와 낮은 침습 수술에 대한 의식이 높아짐에 따라 관심이 급속히 높아지고 있습니다. 경쟁 구도는 전략적 제휴와 합병에 의해 뚜렷해지고 있으며, 각 회사는 제품 포트폴리오와 지역적 리치의 확대를 목표로 하고 있습니다. 미래 전망으로는 기술의 진보와 외과적개입을 필요로 하는 만성질환의 만연 증가에 힘입어 시장은 강력한 성장을 이룰 것으로 보입니다.

주요 동향 및 촉진요인:

차세대 수술용 접착제 시장은 기술의 진보와 낮은 침습 수술 수요 증가에 의해 강력한 성장을 이루고 있습니다. 수술 결과를 찾고 환자의 합병증과 회복에 필요한 시간을 단축하고 싶다는 요구가 있습니다. 또한 규제 당국의 승인과 유리한 상환 정책이 시장 확대를 촉진하고 있습니다. 신흥 시장에는 비즈니스 기회가 가득합니다. 신규 접착제 처방의 연구개발에 투자하고 있는 기업은 이러한 새로운 기회를 활용하는 좋은 위치에 놓여 있습니다.

억제와 도전:

차세대 수술용 접착제 시장에는 몇 가지 심각한 억제요인과 과제가 있습니다. 에 진입하는 속도에 영향을 미칩니다. 또한 연구개발비용이 장벽이 되고, 중소기업의 진입을 제한하고, 혁신을 저해하고 있습니다. 또한 시장은 봉합사나 스테이플이라고 하는 기존 상처 폐쇄법과의 경쟁에 직면하고 있습니다. 이들은 확립된 방법이며, 의료 종사자의 신뢰도 두껍습니다. 마지막으로, 지역에 따라 의료 인프라가 다르기 때문에 접근과 유통에 격차가 생겨 신흥국 시장에의 침투를 방해하고 있습니다.

목차

제1장 차세대 수술용 접착제 시장 개요

제2장 주요 요약

제3장 시장에 관한 중요 인사이트

제4장 차세대 수술용 접착제 시장 전망

제5장 차세대 수술용 접착제 시장 전략

제6장 차세대 수술용 접착제 시장 규모

제7장 차세대 수술용 접착제 시장 : 유형별

제8장 차세대 수술용 접착제 시장 : 제품별

제9장 차세대 수술용 접착제 시장 : 용도별

제10장 차세대 수술용 접착제 시장 : 재료 유형별

제11장 차세대 수술용 접착제 시장 : 기술별

제12장 차세대 수술용 접착제 시장 : 최종 사용자별

제13장 차세대 수술용 접착제 시장 : 형상별

제14장 차세대 수술용 접착제 시장 : 기능성별

제15장 차세대 수술용 접착제 시장 : 전개별

제16장 차세대 수술용 접착제 시장 : 솔루션별

제17장 차세대 수술용 접착제 시장 : 지역별

제18장 경쟁 구도

제19장 기업 프로파일

JHS
영문 목차

영문목차

Next Generation Surgical Glue Market is anticipated to expand from $2.8 billion in 2024 to $8.3 billion by 2034, growing at a CAGR of approximately 11.5%. The market encompasses advanced adhesive solutions designed for medical procedures, offering superior bonding, biocompatibility, and hemostatic properties. These glues facilitate minimally invasive surgeries by reducing recovery times and minimizing infection risks. Innovations focus on bioresorbable materials and enhanced elasticity, catering to diverse applications in cardiovascular, orthopedic, and cosmetic surgeries. The market is driven by rising surgical volumes and demand for safer, faster healing alternatives to traditional sutures and staples.

Market Overview:

The Next Generation Surgical Glue Market is experiencing robust expansion, primarily driven by the increasing need for advanced wound closure solutions that enhance healing and reduce recovery time. The synthetic segment leads the market, with its dominance attributed to superior adhesive properties, biocompatibility, and minimal risk of infection. Innovations in polymer technology have further propelled this segment, offering enhanced strength and flexibility. The natural segment, encompassing fibrin-based glues, is gaining traction due to their biodegradability and reduced inflammatory response. Within this context, the emerging sub-segment of bioactive glues, which incorporate growth factors to facilitate tissue regeneration, holds significant potential. This sub-segment is poised to impact the market by addressing complex surgical needs and improving patient outcomes. Additionally, the rise in minimally invasive surgeries is driving demand for surgical glues that offer precise application and strong adhesion, further solidifying the market's growth trajectory.

Market Segmentation
TypeSynthetic, Natural
ProductLiquid Adhesives, Pastes, Films
ApplicationInternal Surgeries, External Surgeries, Wound Closure, Tissue Sealing, Hemostasis
Material TypeCyanoacrylates, Fibrin Sealants, Collagen-based, Polymeric Hydrogels
TechnologyNano-technology, Bio-adhesive Technology
End UserHospitals, Ambulatory Surgical Centers, Clinics
FormLiquid, Gel, Spray
FunctionalityAdhesion, Sealing, Hemostasis, Tissue Engineering
DeploymentDisposable, Reusable
SolutionsWound Care Solutions, Surgical Solutions

The Next Generation Surgical Glue Market is experiencing a dynamic shift, driven predominantly by innovations in biocompatible and biodegradable adhesives. This market's segmentation reveals a leading preference for synthetic glue types, closely followed by natural-based alternatives. The demand is notably strong in North America and Europe, where advanced healthcare infrastructures and increased surgical procedures propel adoption. Meanwhile, the Asia-Pacific region is witnessing a burgeoning interest, attributed to the expansion of healthcare facilities and rising awareness of minimally invasive surgical techniques. Key players are leveraging research and development to enhance product efficacy and safety, thereby fortifying their market positions. The competitive landscape is marked by strategic collaborations and mergers, with companies aiming to expand their product portfolios and geographic reach. Regulatory influences, particularly in the United States and Europe, emphasize stringent safety and efficacy standards, which shape the market's development trajectory. As we look ahead, the market is poised for robust growth, underpinned by technological advancements and the increasing prevalence of chronic diseases necessitating surgical interventions. However, challenges such as high development costs and regulatory hurdles persist. Nonetheless, the integration of nanotechnology and bioengineering innovations presents promising avenues for future market expansion.

Geographical Overview:

The Next Generation Surgical Glue Market is witnessing varied growth patterns across different regions. North America dominates the landscape, propelled by advanced healthcare infrastructure and substantial R&D investments. The region's focus on minimally invasive surgeries further fuels this demand. Europe trails closely, with a strong emphasis on innovative medical technologies and robust regulatory frameworks. The continent's aging population also contributes to increased surgical procedures, enhancing market prospects. In Asia Pacific, rapid technological advancements and growing healthcare expenditures drive market expansion. Countries like China and India are at the forefront, investing in cutting-edge medical solutions. The region's burgeoning middle class and rising awareness of advanced surgical options further bolster growth. Latin America presents emerging opportunities, with improving healthcare access and increasing adoption of novel medical technologies. The Middle East & Africa region, though nascent, shows promising potential. Investments in healthcare infrastructure and a growing focus on modern medical practices underpin regional growth. As these regions continue to evolve, the Next Generation Surgical Glue Market is poised for significant advancements, offering lucrative opportunities for stakeholders.

Recent Development:

The Next Generation Surgical Glue Market has witnessed pivotal developments recently. Johnson & Johnson announced a strategic partnership with a leading biotech firm to enhance their surgical adhesive technology, aiming to improve post-operative outcomes. In a significant move, Baxter International acquired a promising startup specializing in bio-compatible surgical glues, enhancing their product portfolio and market reach. 3M revealed a breakthrough in their surgical glue formulation, claiming enhanced adhesion and reduced recovery time, which has garnered attention from major healthcare providers. Medtronic unveiled its latest innovation in surgical adhesives, focusing on minimally invasive procedures, positioning itself as a leader in the market. Lastly, a regulatory update from the European Medicines Agency has streamlined the approval process for next-generation surgical glues, potentially accelerating market entry for new products. These developments underscore the dynamic nature of the market, driven by strategic collaborations, innovative breakthroughs, and favorable regulatory changes.

Key Trends and Drivers:

The Next Generation Surgical Glue Market is experiencing robust growth due to technological advancements and increased demand for minimally invasive procedures. Key trends include the development of bio-based adhesives that offer superior biocompatibility and enhanced healing properties. These innovations are driven by the need for safer and more efficient surgical outcomes, reducing complications and recovery time for patients. Furthermore, the rise in surgical procedures due to an aging global population is a significant driver. As healthcare systems strive to improve patient outcomes, the adoption of advanced surgical adhesives is becoming more prevalent. Additionally, regulatory approvals and favorable reimbursement policies are facilitating market expansion. The growing focus on reducing surgical costs and hospital stays is promoting the use of surgical glues over traditional sutures and staples. Opportunities abound in emerging markets where healthcare infrastructure is rapidly improving. Companies investing in research and development to create novel adhesive formulations are well-positioned to capitalize on these emerging opportunities. The market's future is promising, with continuous innovation and strategic partnerships expected to propel growth.

Restraints and Challenges:

The Next Generation Surgical Glue Market encounters several significant restraints and challenges. A primary restraint is the stringent regulatory landscape, which delays product approvals and increases compliance costs. This affects the speed at which new products can enter the market. Additionally, the high cost of research and development acts as a barrier, limiting the entry of smaller players and stifling innovation. Another challenge is the limited awareness and understanding of these advanced products among healthcare professionals, which hinders widespread adoption. Furthermore, the market faces competition from traditional wound closure methods, such as sutures and staples, which are well-established and trusted by practitioners. Lastly, the varying healthcare infrastructure across regions creates disparities in access and distribution, impeding market penetration in developing areas. These challenges collectively slow the market's growth and limit the reach of next-generation surgical glues.

Key Companies:

Adhesion Biomedical, Baxter International, Cohera Medical, Cryo Life, Gecko Biomedical, Glu Stitch, Integra Life Sciences, Johnson & Johnson, Medtronic, Meyer- Haake, Opt Med, Peters Surgical, Sealantis, Stryker Corporation, Tissuemed, Vivostat, Advanced Medical Solutions Group, B. Braun Melsungen, Arch Therapeutics, Chemence Medical

Sources:

U.S. Food and Drug Administration (FDA) - Center for Devices and Radiological Health, European Medicines Agency (EMA), World Health Organization (WHO), National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), American Association for the Advancement of Science (AAAS), International Society for Technology in Arthroplasty (ISTA), Biomedical Engineering Society (BMES), International Conference on Biomedical Engineering and Technology (ICBET), Advanced Medical Technology Association (AdvaMed), International Society for Biofabrication (ISBF), National Institute of Biomedical Imaging and Bioengineering (NIBIB), European Society for Biomaterials (ESB), American Society of Mechanical Engineers (ASME) - Bioengineering Division, International Conference on Tissue Engineering and Regenerative Medicine, International Society for Cellular Therapy (ISCT), U.S. National Library of Medicine (NLM), International Conference on Biomaterials, International Society for Stem Cell Research (ISSCR), American Chemical Society (ACS) - Division of Polymer Chemistry

Research Scope:

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Next-Generation Surgical Glue Market Overview

2: Executive Summary

3: Premium Insights on the Market

4: Next-Generation Surgical Glue Market Outlook

5: Next-Generation Surgical Glue Market Strategy

6: Next-Generation Surgical Glue Market Size

7: Next-Generation Surgical Glue Market, by Type

8: Next-Generation Surgical Glue Market, by Product

9: Next-Generation Surgical Glue Market, by Application

10: Next-Generation Surgical Glue Market, by Material Type

11: Next-Generation Surgical Glue Market, by Technology

12: Next-Generation Surgical Glue Market, by End User

13: Next-Generation Surgical Glue Market, by Form

14: Next-Generation Surgical Glue Market, by Functionality

15: Next-Generation Surgical Glue Market, by Deployment

16: Next-Generation Surgical Glue Market, by Solutions

17: Next-Generation Surgical Glue Market, by Region

18: Competitive Landscape

19: Company Profiles

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기